Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board; Notice of Meeting, 34418-34419 [06-5352]

Download as PDF rwilkins on PROD1PC63 with NOTICES 34418 Federal Register / Vol. 71, No. 114 / Wednesday, June 14, 2006 / Notices equivalency deposits on the depository bank’s books and records. • The funds deposited and obligations that are placed in safekeeping at a depository bank to satisfy a foreign bank’s capital equivalency deposit requirement must be maintained pursuant to an agreement prescribed by the OCC that shall be a written agreement entered into with the OCC. Maintenance of capital equivalency ledger account: Each Federal branch or agency shall maintain a capital equivalency account and keep records of the amount of liabilities requiring capital equivalency coverage in a manner and form prescribed by the OCC. 12 CFR 28.15(d)(1) Capital Equivalency Deposits—Deposit Arrangements: A foreign bank’s capital equivalency deposits may not be reduced in value below the minimum required for that branch or agency without the prior approval of the OCC, but in no event below the statutory minimum. 12 CFR 28.16(c) Deposit-taking by an Uninsured Federal branch—Application for an Exemption: A foreign bank may apply to the OCC for an exemption to permit an uninsured Federal branch to accept or maintain deposit accounts that are not listed in paragraph (b) of this section. The request should describe: • The types, sources, and estimated amount of such deposits and explain why the OCC should grant an exemption; • How the exemption maintains and furthers the policies described in paragraph (a) of this section. 12 CFR 28.16(d) Deposit taking by an uninsured Federal branch—Aggregation of deposits: A foreign bank that has more than one Federal branch in the same state may aggregate deposits in all of its Federal branches in that state, but exclude deposits of other branches, agencies or wholly owned subsidiaries of the bank. The Federal branch shall compute the average amount by using the sum of deposits as of the close of business of the last 30 calendar days ending with and including the last day of the calendar quarter, divided by 30. The Federal branch shall maintain records of the calculation until its next examination by the OCC. 12 CFR 28.17 Covered under Information Collection 1557–0014 (Comptroller’s Licensing Manual) Notice of Change in Activity or Operations: A Federal branch or agency shall notify the OCC if it changes its corporate title; changes its mailing address; converts to a state branch, state agency, or representative office; or the parent VerDate Aug<31>2005 19:47 Jun 13, 2006 Jkt 208001 foreign bank changes the designation of its home state. 12 CFR 28.18(c)(1) Recordkeeping and Reporting—Maintenance of Accounts, Books, and Records: Each Federal branch or agency shall maintain a set of accounts and records reflecting its transactions that are separate from those of the foreign bank and any other branch or agency. The Federal branch or agency shall keep a set of accounts and records in English sufficient to permit the OCC to examine the condition of the Federal branch or agency and its compliance with applicable laws and regulations. 28.20(a)(1) Maintenance of Assets— General Rule: The OCC may require a foreign bank to hold certain assets, with the approval of the OCC, in the state in which its Federal branch or agency is located. 12 CFR 28.22 (b) Covered under Information Collection 1557–0014 (Comptroller’s Licensing Manual) Voluntary Liquidation: Notice to customers and creditors—A foreign bank shall publish notice of the impending closure of each Federal branch or agency for a period of two months in every issue of a local newspaper where the Federal branch or agency is located. If only weekly publication is available, the notice must be published for nine consecutive weeks. 12 CFR 28.22(e) Reports of Examination: The Federal branch or agency shall send the OCC certification that all of its Reports of Examination have been destroyed or return its Reports of Examination to the OCC. 12 CFR 28.25(a) Covered under Information Collection 1557–0014 (Comptroller’s Licensing Manual) Change in Control—After-the-fact Notice: A foreign bank that operates a Federal branch or agency shall inform the OCC in writing of the direct or indirect acquisition of control of the foreign bank by any person or entity, or group of persons or entities acting in concert, within 14 calendar days after the foreign bank becomes aware of a change in control. 12 CFR 28.52 Covered under Information Collection 1557–0081 (MA)—Reports of Condition and Income (Interagency Call Report), FFIEC 031, FFIEC 041 Allocated Transfer Risk Reserve: A banking institution shall establish an allocated transfer risk reserve for specified international assets when required by the OCC. 12 CFR 28.53 Accounting for Fees on International Loans: Sets forth restrictions on fees and specifies accounting treatment for international loans. PO 00000 Frm 00119 Fmt 4703 Sfmt 4703 12 CFR 28.54 Covered under Information Collection 1557–0100 Country Exposure Report and Country Exposure Information Report (FFIEC 009, FFIEC 009a) Reporting and Disclosure of International Assets: A banking institution shall submit to the OCC, at least quarterly, information regarding the amounts and composition of its holdings of international assets. A banking institution shall submit to the OCC information regarding concentrations in its holdings of international assets that are material in relation to total assets and to capital of the institution. Type of Review: Extension of a currently approved collection. Affected Public: Individuals; Businesses or other for-profit. Estimated Number of Respondents: 79. Estimated Total Annual Responses: 117. Frequency of Response: On occasion. Estimated Total Annual Burden: 3,661.5. All comments will become a matter of public record. Comments are invited on: (a) Whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information has practical utility; (b) The accuracy of the agency’s estimate of the burden of the collection of information; (c) Ways to enhance the quality, utility, and clarity of the information to be collected; (d) Ways to minimize the burden of the collection on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) Estimates of capital or startup costs and costs of operation, maintenance, and purchase of services to provide information. Dated: June 8, 2006. Stuart Feldstein, Assistant Director, Legislative and Regulatory Activities Division. [FR Doc. E6–9229 Filed 6–13–06; 8:45 am] BILLING CODE 4810–33–P DEPARTMENT OF VETERANS AFFAIRS Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board; Notice of Meeting The Department of Veterans Affairs gives notice under the Public Law 92– E:\FR\FM\14JNN1.SGM 14JNN1 Federal Register / Vol. 71, No. 114 / Wednesday, June 14, 2006 / Notices rwilkins on PROD1PC63 with NOTICES 463 (Federal Advisory Committee Act) that a subcommittee of the Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board will meet from 8 a.m. to 5 p.m. on August 1, 2006 at the Doubletree Hotel, 1515 Rhode Island Ave., NW., Washington, DC. The subcommittee meeting will focus on evaluating Pharmacogenomics Analysis Laboratory proposals submitted by VA investigators. The purpose of the Merit Review Board is to provide advice on the scientific quality, budget, safety and mission relevance of center-based research proposals submitted for VA merit review consideration. Proposals submitted for review by the Board involve a range of medical specialties within the general areas of biomedical, behavioral and clinical science research. VerDate Aug<31>2005 19:47 Jun 13, 2006 Jkt 208001 The subcommittee meeting will be open to the public for approximately one hour at the start of its meeting to discuss the general status of the program. The remaining portion of the meeting will be closed to the public for the review, discussion, and evaluation of initial and renewal projects. The closed portion of the meeting involves discussion, examination, and reference to staff and consultant critiques of research protocols. During this portion of the subcommittee meeting, discussion and recommendations will deal with qualifications of personnel conducting the studies, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy, as well as research information, the premature disclosure of which could significantly frustrate implementation of proposed PO 00000 Frm 00120 Fmt 4703 Sfmt 4703 34419 agency action regarding such research projects. As provided by subsection 10(d) of Public Law 92–463, as amended, closing portions of this meeting is in accordance with 5 U.S.C., 552b(c)(6) and (9)(B). Those who plan to attend or would like to obtain a copy of minutes of the subcommittee meeting and a roster of the members of the subcommittee should contact LeRoy G. Frey, PhD., Chief, Program Review (121F), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420 at (202) 254–0288. Dated: June 2, 2006. By direction of the Secretary. E. Philip Riggin, Committee Management Officer. [FR Doc. 06–5352 Filed 6–13–06; 8:45 am] BILLING CODE 8320–01–M E:\FR\FM\14JNN1.SGM 14JNN1

Agencies

[Federal Register Volume 71, Number 114 (Wednesday, June 14, 2006)]
[Notices]
[Pages 34418-34419]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5352]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review 
Board; Notice of Meeting

    The Department of Veterans Affairs gives notice under the Public 
Law 92-

[[Page 34419]]

463 (Federal Advisory Committee Act) that a subcommittee of the Joint 
Biomedical Laboratory Research and Development and Clinical Science 
Research and Development Services Scientific Merit Review Board will 
meet from 8 a.m. to 5 p.m. on August 1, 2006 at the Doubletree Hotel, 
1515 Rhode Island Ave., NW., Washington, DC. The subcommittee meeting 
will focus on evaluating Pharmacogenomics Analysis Laboratory proposals 
submitted by VA investigators.
    The purpose of the Merit Review Board is to provide advice on the 
scientific quality, budget, safety and mission relevance of center-
based research proposals submitted for VA merit review consideration. 
Proposals submitted for review by the Board involve a range of medical 
specialties within the general areas of biomedical, behavioral and 
clinical science research.
    The subcommittee meeting will be open to the public for 
approximately one hour at the start of its meeting to discuss the 
general status of the program. The remaining portion of the meeting 
will be closed to the public for the review, discussion, and evaluation 
of initial and renewal projects.
    The closed portion of the meeting involves discussion, examination, 
and reference to staff and consultant critiques of research protocols. 
During this portion of the subcommittee meeting, discussion and 
recommendations will deal with qualifications of personnel conducting 
the studies, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy, as well as research 
information, the premature disclosure of which could significantly 
frustrate implementation of proposed agency action regarding such 
research projects.
    As provided by subsection 10(d) of Public Law 92-463, as amended, 
closing portions of this meeting is in accordance with 5 U.S.C., 
552b(c)(6) and (9)(B). Those who plan to attend or would like to obtain 
a copy of minutes of the subcommittee meeting and a roster of the 
members of the subcommittee should contact LeRoy G. Frey, PhD., Chief, 
Program Review (121F), Department of Veterans Affairs, 810 Vermont 
Avenue, NW., Washington, DC 20420 at (202) 254-0288.

    Dated: June 2, 2006.

    By direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. 06-5352 Filed 6-13-06; 8:45 am]
BILLING CODE 8320-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.